Rivastigmin Zentiva Patch 4.6 mg/24 h

Rivastigmin Zentiva Patch 4.6 mg/24 h is a medicine authorised by Swissmedic under authorisation number 62917. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 March 2014 and the authorisation is valid without a time limit. ATC code N06DA03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 62917
  • ATC N06DA03
  • Synthetic medicines
Authorisation data
Authorisation number62917
NameRivastigmin Zentiva Patch 4.6 mg/24 h
Full nameRivastigmin Zentiva Patch 4.6 mg/24 h, transdermales Pflaster
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA03
First authorisation27 March 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Rivastigmin Zentiva Patch 4.6 mg/24 h, transdermales PflasterB27 March 2014
2Rivastigmin Zentiva Patch 9.5 mg/24 h, transdermales PflasterB27 March 2014
3Rivastigmin Zentiva Patch 13.3 mg/24 h, transdermales PflasterB11 February 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
730PflasterN06DA0301.99.0.B
830PflasterN06DA0301.99.0.B
92 x 30PflasterN06DA0301.99.0.B
1030PflasterN06DA0301.99.0.B
112 x 30PflasterN06DA0301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivastigmin Zentiva Patch 4.6 mg/24 h authorised in Switzerland?

Yes. Rivastigmin Zentiva Patch 4.6 mg/24 h is authorised by Swissmedic under authorisation number 62917, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Rivastigmin Zentiva Patch 4.6 mg/24 h have?

Rivastigmin Zentiva Patch 4.6 mg/24 h is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivastigmin Zentiva Patch 4.6 mg/24 h?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com